Glaucoma Clinical Trials in Baltimore, Maryland

5 studies are recruiting for glaucoma in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

    This pilot study evaluates the biomechanical properties of the cornea in glaucoma patients using Brillouin microscopy, a non-contact imaging technique. The study aims to compare corneal stiffness between patients with normal-tension glaucoma, high-tension glaucoma, and healthy controls, and to asse…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Maryland School of Medicine, Baltimore, Maryland
    Run by
    University of Maryland, Baltimore
  2. Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland
    Locations
    8 in total
    Run by
    University of Pennsylvania
  3. Optic Nerve Head Strain in Non-glaucoma Subjects

    Persons who do not have glaucoma will have pictures taken of the optic nerve with a standard camera before and 2 weeks after starting to take a daily glaucoma eye drop to lower eye pressure. These data will be used to compare to the same procedure performed with glaucoma patients to study how glauc…

    Stage
    EARLY_Phase 1
    Ages
    30 to 90
    Site
    Johns Hopkins Hospital, Baltimore, Maryland
    Run by
    Johns Hopkins University
  4. Ocular Blood Flow Imaging for Glaucoma Assessment

    The goal of this clinical trial is to investigate the use of an FDA-cleared retinal blood flow imaging instrument called the XyCAM RI and XyCAM FC (Vasoptic Medical, Inc., Columbia, MD) in glaucoma management. The main question it aims to answer are: * Can the investigators use blood flow to discri…

    Stage
    Not phased
    Ages
    18 to 88
    Site
    University of Maryland Eye Associates at Redwood, Baltimore, Maryland
    Run by
    University of Maryland, Baltimore
  5. Retinal Blood Flow and Autoregulation

    The purpose of this study is to establish autoregulation of retinal blood flow in arterioles and capillaries as a biomarker for early primary open angle glaucoma.

    Stage
    Phase 4
    Ages
    18 to 88
    Site
    University of Maryland Faculty Physicians, Inc, Baltimore, Maryland
    Locations
    4 in total
    Run by
    University of Maryland, Baltimore

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.